BARD1 and cancer: Interestingly, BARD1 splice isoforms, which lack the RING domain, such as BARD1-β and -δ, show effects that are antagonistic to that of BARD1-FL, and have been associated with progression and poor prognosis in multiple cancer types [17,18,19].